Mafalda Malafaia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mafalda Malafaia has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- António Cunha
Universidade de Trás-os-Montes e Alto Douro
1 shared publication - António J. Madureira
CHUSJ—Centro Hospitalar e Universitário de São João, 4200-319 Porto, Portugal
1 shared publication - Beatriz Flor de Lima
CHUSJ—Centro Hospitalar e Universitário de São João, 4200-319 Porto, Portugal
1 shared publication - Cláudia Freitas
CHUSJ—Centro Hospitalar e Universitário de São João, 4200-319 Porto, Portugal
1 shared publication - Eduardo Negrão
CHUSJ—Centro Hospitalar e Universitário de São João, 4200-319 Porto, Portugal
1 shared publication - Francisco Silva
INESC TEC—Institute for Systems and Computer Engineering, Technology and Science, 4200-465 Porto, Portugal
1 shared publication
Latest Publications
- Open Access
- 16 March 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (3) , 480
Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
Advancements in the development of computer-aided decision (CAD) systems for clinical routines provide unquestionable benefits in connecting human medical expertise with machine intelligence, to achieve better quality healthcare. Considering the large number of incidences and mortality numbers associated with lung cancer, there is a need for the most accurate clinical procedures; thus, the possibility of using artificial intelligence (AI) tools for decision support is becoming a closer reality. At any stage of the lung cancer clinical pathway, specific obstacles are identified and “motivate” the application of innovative AI solutions. This work provides a comprehensive review of the most recent research dedicated toward the development of CAD tools using computed tomography images for lung cancer-related tasks. We discuss the major challenges and provide critical perspectives on future directions. Although we focus on lung cancer in this review, we also provide a more clear definition of the path used to integrate AI in healthcare, emphasizing fundamental research points that are crucial for overcoming current barriers.
- 16 March 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (3) , 480
Open AccessTowards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
Advancements in the development of computer-aided decision (CAD) systems for clinical routines provide unquestionable benefits in connecting human medical expertise with machine intelligence, to achieve better quality healthcare. Considering the large number of incidences and mortality numbers associated with lung cancer, there is a need for the most accurate clinical procedures; thus, the possibility of using artificial intelligence (AI) tools for decision support is becoming a closer reality. At any stage of the lung cancer clinical pathway, specific obstacles are identified and “motivate” the application of innovative AI solutions. This work provides a comprehensive review of the most recent research dedicated toward the development of CAD tools using computed tomography images for lung cancer-related tasks. We discuss the major challenges and provide critical perspectives on future directions. Although we focus on lung cancer in this review, we also provide a more clear definition of the path used to integrate AI in healthcare, emphasizing fundamental research points that are crucial for overcoming current barriers.